Helix has released a new suite of pharmacogenomics (PGx) tests, widening its portfolio in neurology and oncology.

HistoSonics' Edison histotripsy system has been granted controlled early limited market access in the UK under an Unmet ...

BD is set to commence a multi-centre registry study, XTRACT, of the Rotarex Atherectomy System, for peripheral artery disease ...

Illumina is expanding access to its oncology range of IVD tests, as its TruSight Oncology Comprehensive IVD is now covered ...

The FDA has granted 510(k) clearance for Distalmotion’s DEXTER robotic surgery system to be used in adult cholecystectomies.

The US structural heart occlusion (SHO) market recorded a strong 39% year-over-year revenue increase in the first quarter (Q1 ...

The CEO of Flow Neuroscience has called out the US Food and Drug Administration (FDA) for market entry delays for clinically ...

NeuroPace has reported the initial primary endpoint one-year outcomes from the NAUTILUS trial of the RNS System.

Danish medtech Brainreader has secured $7.3m (€6.6m) to support the market rollout of Neuroreader, its artificial ...

SAGA Diagnostics has commercially launched the multi-cancer molecular residual disease (MRD) platform, Pathlight, in the US.

The US Food and Drug Administration (FDA) has granted approval for Abbott's Tendyne transcatheter mitral valve replacement ...

With the 78th World Health Assembly ending today, all eyes have been on this year’s World Health Organization (WHO) member’s ...